Literature DB >> 9774285

Fluoroquinolone resistance: overuse of fluoroquinolones in human and veterinary medicine can breed resistance.

L J Piddock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9774285      PMCID： PMC1114060          DOI： 10.1136/bmj.317.7165.1029

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

Review 1.  Overlaps and parallels in the regulation of intrinsic multiple-antibiotic resistance in Escherichia coli.

Authors:  P F Miller; M C Sulavik
Journal:  Mol Microbiol       Date:  1996-08       Impact factor: 3.501

2.  Ciprofloxacin resistant Campylobacter spp. in humans: an epidemiological and laboratory study.

Authors:  P N Gaunt; L J Piddock
Journal:  J Antimicrob Chemother       Date:  1996-04       Impact factor: 5.790

3.  Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals.

Authors:  M J Everett; Y F Jin; V Ricci; L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

4.  Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance.

Authors:  X S Pan; L M Fisher
Journal:  J Bacteriol       Date:  1996-07       Impact factor: 3.490

5.  Quinolone resistance from a transferable plasmid.

Authors:  L Martínez-Martínez; A Pascual; G A Jacoby
Journal:  Lancet       Date:  1998-03-14       Impact factor: 79.321

6.  Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment.

Authors:  J Wain; N T Hoa; N T Chinh; H Vinh; M J Everett; T S Diep; N P Day; T Solomon; N J White; L J Piddock; C M Parry
Journal:  Clin Infect Dis       Date:  1997-12       Impact factor: 9.079

7.  Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations.

Authors:  H E Takiff; L Salazar; C Guerrero; W Philipp; W M Huang; B Kreiswirth; S T Cole; W R Jacobs; A Telenti
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

8.  Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon.

Authors:  K Poole; K Krebes; C McNally; S Neshat
Journal:  J Bacteriol       Date:  1993-11       Impact factor: 3.490

9.  Quinolone resistance in veterinary isolates of Salmonella.

Authors:  D J Griggs; M C Hall; Y F Jin; L J Piddock
Journal:  J Antimicrob Chemother       Date:  1994-06       Impact factor: 5.790

10.  Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus.

Authors:  G W Kaatz; S M Seo; C A Ruble
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191
View more
  10 in total

Review 1.  Antibiotic resistance: a current perspective.

Authors:  K F Barker
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

2.  Increasing rates of ciprofloxacin resistant campylobacter.

Authors:  W I Sam; M M Lyons; D J Waghorn
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

3.  Fluoroquinolone resistance in salmonellas and campylobacters from humans.

Authors:  E J Threlfall; J A Frost; B Rowe
Journal:  BMJ       Date:  1999-04-03

4.  Independent behavior of commensal flora for carriage of fluoroquinolone-resistant bacteria in patients at admission.

Authors:  Victoire de Lastours; Françoise Chau; Florence Tubach; Blandine Pasquet; Etienne Ruppé; Bruno Fantin
Journal:  Antimicrob Agents Chemother       Date:  2010-09-27       Impact factor: 5.191

5.  Ciprofloxacin dosage and emergence of resistance in human commensal bacteria.

Authors:  Bruno Fantin; Xavier Duval; Laurent Massias; Loubna Alavoine; Françoise Chau; Sylvie Retout; Antoine Andremont; France Mentré
Journal:  J Infect Dis       Date:  2009-08-01       Impact factor: 5.226

Review 6.  Acute exacerbations of chronic bronchitis: what role for the new fluoroquinolones?

Authors:  A Obaji; S Sethi
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

7.  In vitro assessment of the further potential for development of fluoroquinolone resistance in Neisseria meningitidis.

Authors:  Tiffany R Shultz; Peter A White; John W Tapsall
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

Review 8.  Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin.

Authors:  Elda Righi; Alessia Carnelutti; Antonio Vena; Matteo Bassetti
Journal:  Infect Drug Resist       Date:  2018-04-04       Impact factor: 4.003

9.  Ciprofloxacin susceptibility reduction of Salmonella strains isolated from outbreaks.

Authors:  Roberta B Souza; Rafaela G Ferrari; Marciane Magnani; Luciana B M Kottwitz; Iliana Alcocer; Maria Cristina B Tognim; Tereza C R M Oliveira
Journal:  Braz J Microbiol       Date:  2010-06-01       Impact factor: 2.476

Review 10.  Bacterial antibiotic resistance development and mutagenesis following exposure to subinhibitory concentrations of fluoroquinolones in vitro: a systematic review of the literature.

Authors:  Carly Ching; Ebiowei S F Orubu; Indorica Sutradhar; Veronika J Wirtz; Helen W Boucher; Muhammad H Zaman
Journal:  JAC Antimicrob Resist       Date:  2020-09-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.